ZKB Law would like to extend a special, “Thank you!” to Chris Cuomo of ABC News not only for his in-depth coverage on the dangers of Yaz, Yasmin and Ocella birth controls, but also for helping us spread the word to women across the country.
Mr. Cuomo was gracious enough to pass along our drug-advocacy website, www.YazYasminAndYou.com, to his 993,400 Twitter followers, which resulted in a tremendous response from our readers, as well as from women taking the drug.
In case you missed his program, you can watch the video of the ABC News story on Yaz, or read the transcript from the show. Mr. Cuomo focused on the health issues that many women are facing, including blood clots or deep-vein thrombosis (DVT) and stroke. He also highlighted the fact that Bayer, the maker of Yaz, allegedly withheld information from the FDA about the increased risks of taking Yaz. The FDA is addressing problems surrounding the Yaz family of birth controls in their Meeting of the Reproductive Health Drugs Advisory Committee today in Maryland. Check out the Agenda for the FDA Yaz meeting, and check back to our site frequently as we continue our coverage of this important event.
Chris Cuomo assured us that he would continue his investigation on Yaz. Check out Chris Cuomo’s website, and follow Chris on Twitter to keep apprised of his great work for ABC News.
Subscribe to:
Post Comments (Atom)
Posts
so since the FDA is only requiring stronger labels, what does this mean to the litigation?
ReplyDeleteWe believe that the required label change will ultimately have a strong positive effect on the ongoing Yaz litigation. We applaud the FDA Advisory Panel’s decision to change the wording, as Zoll, Kranz and Borgess has consistently argued that Bayer’s current labeling fails to adequately warn women about the serious dangers of Drospirenone-containing oral contraceptives, including significant increased risks of blood clots and stroke.
ReplyDelete